Brief: Biotalys, Novozymes Announce Successful Evoca Feasibility Study
Oct 24 (Reuters) - Biotalys NV BTLS.BR :
* BIOTALYS AND NOVOZYMES ANNOUNCE SUCCESSFUL EVOCA™
FEASIBILITY
STUDY
* EVOCA IS EXPECTED TO OBTAIN APPROVAL BY U.S. ENVIRONMENTAL
PROTECTION AGENCY (EPA) IN EARLY 2023
Source text for Eikon: ID:nGNE1GQqnx
Further company coverage: BTLS.BR
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Biotalys NV
See all newsBrief: Biotalys Says EPA Files Decision To Approve Evoca Biofungicide
Brief: Biotalys Appoints Luc Van Fraeyenhoven As Chief Financial Officer
Brief: Ackermans & Van Haaren Invests Additional 5 Million Euros In Biotalys
Brief: Biotalys, Novonesis Enter Into An Agreement
Brief: Biotalys Enters Into Academic Collaborations In Europe And U.S.